Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Not only balloons: Use-cases and key players in global helium market

Whether you’re seeking exposure to exploration upside or established profitability, the helium market offers compelling candidates for the commodity sleeve of your portfolio. Helium is an essential resource notable for its widespread use-cases and p...
Trevor Abes | September 5, 2024 |

AI as a winning model!

200% return with Super Micro Computer and BlockchainK2; caution with Intel and Aixtron! The high-tech wave has been quite pronounced so far in 2024. Even the correction in July had little impact on the strong trend, which is now continuing upward. However, inve...
André Will-Laudien | September 4, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

2024, a breakthrough year for silver

By Chen Lin, chenpicks.com For thousands of years, silver has been a globally recognized commodity. In China, silver was historically used as a standard form of currency, and the term “bank” in Chinese (银行) literally translates to “silver trad...
Research | June 14, 2024 |

Drilling company poised to capitalize on market conditions

The following is a transcription of the above video, and The Market Online has edited it for clarity . AKITA Drilling (TSX:AKT.A) is a leading intermediate North American land drilling contractor that is valued far below its assets with a fleet of 36 high-spec rigs...
Ryan Dhillon | May 28, 2024 |

What is the future of nuclear power in the shift to net zero?

With the global shift to net zero in 2050, sourcing alternative energy sources is imperative. In the Expert Exchange video segment above, we look at nuclear power – the pros and cons, the investment opportunities and its potential role in the electric vehicle (EV) ma...
Coreena Robertson | May 16, 2024 |

Is China getting serious? Rheinmetall and Almonty Industries profit

Is China really preparing for an attack on Taiwan? It is well known that China is massively increasing its gold reserves. But why tungsten, too? After all, China itself is the largest producer of this raw material, which is not only in demand in the arms industry. ...
Fabian Lorenz | April 24, 2024 |

Can Amazon stock retain its Magnificent Seven position?

Amazon.com Inc. (NDAQ:AMZN) is one of the S&P 500’s Magnificent Seven Amazon shares were up more than 85 per cent the past year and have doubled over the past five years Amazon’s target price is around US$200, implying an...
Coreena Robertson | April 17, 2024 |

Targeting Nevada and Ontario for the critical minerals supply chain

The following is a transcription of the above video, and The Market Online has edited it for clarity . Fuse Battery Metals Inc. (TSXV:FUSE) , is a tier two mining exploration company focused on the exploration and development of strategic metals, particularly lithiu...
Ryan Dhillon | April 12, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |
1 2 3 4 5 6 7 8 9 10 ...